In This Story
Green Planet Bioengineering Co., Ltd. has submitted its 10-Q filing for the quarterly period ended September 30, 2024.
The filing indicates that the company had no active business operations during this period. Expenses primarily consisted of accounting and filing fees.
The company reported a net loss of $22,753 for the nine months ended September 30, 2024, compared to a net loss of $34,120 for the same period in the previous year.
Green Planet Bioengineering Co., Ltd. is currently a public reorganized shell corporation with the purpose of acquiring or merging with an existing business operation.
The company has a working capital deficit of $452,343 and an accumulated deficit of $1,081,963 as of September 30, 2024.
All cash flow needs for the period were met through advances from a related party of the majority stockholder.
The company acknowledges substantial doubt about its ability to continue as a going concern without continued support from related parties.
The filing contains no information on any commitments or contingencies during the reporting period.
Green Planet Bioengineering Co., Ltd. has not issued any shares of common stock or warrants during the nine months ended September 30, 2024.
The company does not have any off-balance sheet arrangements that could materially affect its financial condition.
This content was summarized by generative artificial intelligence using public filings retrieved from SEC.gov. The original data was derived from the Green Planet Bioengineering Co Ltd quarterly 10-Q report dated November 14, 2024. To report an error, please email earnings@qz.com.